23.3 C
Vientiane
Thursday, February 27, 2025
spot_img

Cision PR Newswire

AIM Vaccine’s mRNA RSV Vaccine Approved for U.S. Clinical Trials

Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd.(a joint stock company incorporated in the People's Republic of China with limited liability)(Stock Code: 6660.HK) HONG KONG, Feb. 27, 2025 /PRNewswire/ -- The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend....

Similarvideo Unveils AI Talking Avatar to Transform Video Creation

NEW YORK, Jan. 14, 2025 /PRNewswire/ -- Similarvideo, a leader in AI viral video generator, has announced the launch of its revolutionary AI Talking Avatar...

MicroAire appoints Remco Maljers as Head of International Sales

CHARLOTTESVILLE, Va., Jan. 14, 2025 /PRNewswire/ -- MicroAire Surgical Instruments, a Marmon Holdings | Berkshire Hathaway company focused on plastic and upper extremity surgery,...

URSROBOT Celebrates a Successful Showcase of NEXMOW M2 at CES 2025

LAS VEGAS, Jan. 14, 2025 /PRNewswire/ -- URSROBOT, a leader in AI-driven robotics, is delighted to announce the resounding success of its presentation of...

Baseus Wins Three Prestigious Awards Following CES 2025 Innovation Honors

LAS VEGAS, Jan. 14, 2025 /PRNewswire/ -- Building on the momentum of winning two CES Innovation Awards earlier this year, Baseus has achieved yet another...

ROMOSS Showcases Latest Charging Innovations at CES 2025, Paving the Way for Global Market Expansion

LAS VEGAS, Jan. 14, 2025 /PRNewswire/ -- At CES 2025, held from January 7-10 in Las Vegas, ROMOSS captivated global audiences with its latest charging...

BioCina and NovaCina Merger Bolsters Global CDMO Industry

ADELAIDE, South Australia and PERTH, Western Australia, Jan. 14, 2025 /PRNewswire/ -- Global Contract Development and Manufacturing Organizations (CDMOs) BioCina and NovaCina announced a...